SlideShare a Scribd company logo
Health Policy
www.thelancet.com Published online March 12, 2019 https://doi.org/10.1016/S0140-6736(20)30627-9	 1
COVID-19 and Italy: what next?
Andrea Remuzzi, Giuseppe Remuzzi
The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already taken on pandemic
proportions, affecting over 100 countries in a matter of weeks. A global response to prepare health systems worldwide is
imperative. Although containment measures in China have reduced new cases by more than 90%, this reduction is not
the case elsewhere, and Italy has been particularly affected. There is now grave concern regarding the Italian national
health system’s capacity to effectively respond to the needs of patients who are infected and require intensive care for
SARS-CoV-2 pneumonia. The percentage of patients in intensive care reported daily in Italy between March 1 and
March 11, 2020, has consistently been between 9% and 11% of patients who are actively infected. The number of patients
infected since Feb 21 in Italy closely follows an exponential trend. If this trend continues for 1 more week, there will be
30 000 infected patients. Intensive care units will then be at maximum capacity; up to 4000 hospital beds will be needed
by mid-April, 2020. Our analysis might help political leaders and health authorities to allocate enough resources,
including personnel, beds, and intensive care facilities, to manage the situation in the next few days and weeks. If the
Italian outbreak follows a similar trend as in Hubei province, China, the number of newly infected patients could start
to decrease within 3–4 days, departing from the exponential trend. However, this cannot currently be predicted because
of differences between social distancing measures and the capacity to quickly build dedicated facilities in China.
Introduction
According to Nature, the spread of coronavirus disease
2019 (COVID-19) is becoming unstoppable and has
already reached the necessary epidemiological criteria for
it to be declared a pandemic, having infected more than
100 000 people in 100 countries.1
Therefore, a coordinated
global response is desperately needed to prepare health
systems to meet this unprecedented challenge. Countries
that have been unfortunate enough to have been exposed
to this disease already have, paradoxically, very valuable
lessons to pass on. Although the containment measures
implemented in China have—at least for the moment—
reduced new cases by more than 90%, this reduction is
not the case in other countries, including Italy and Iran.2
Italy has had 12 462 confirmed cases according to the
Istituto Superiore di Sanità as of March 11, and 827 deaths.
Only China has recorded more deaths due to this
COVID-19 outbreak. The mean age of those who died in
Italy was 81 years and more than two-thirds of these
patients had diabetes, cardiovascular diseases, or cancer,
or were former smokers. It is therefore true that these
patients had underlying health conditions, but it is also
worth noting that they had acute respiratory distress
syndrome (ARDS) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) pneumonia,
needed respiratory support, and would not have died
otherwise. Of the patients who died, 42·2% were aged
80–89 years, 32·4% were aged 70–79 years, 8·4% were
aged 60–69 years, and 2·8% were aged 50–59 years (those
aged >90 years made up 14·1%). The male to female ratio
is 80% to 20% with an older median age for women
(83·4 years for women vs 79·9 years for men).
On March 8, 2020, the Italian Government imple­mented
extraordinary measures to limit viral transmission—in­
cluding restricting movement in the region of Lombardy—
that intended to minimise the likelihood that people
who are not infected come into contact with people who
are infected. This decision is certainly courageous and
Published Online
March 12, 2020
https://doi.org/10.1016/
S0140-6736(20)30627-9
Department of Management
Information and Production
Engineering, University of
Bergamo, Dalmine, Italy
(Prof A Remuzzi EngD); and
Istituto di Ricerche
Farmacologiche Mario Negri
IRCCS (Prof G Remuzzi MD)
Figure 1: Measured and predicted number of patients reported to be infected in Italy using an exponential
curve
PanelA shows number of infections in previous days and B shows projections forthe coming days.
Feb 19 Feb 21 Feb 23 Feb 25 Feb 27 Feb 29 March 2 March 4 March 6 March 8 March 10
0
1000
2000
3000
4000
5000
6000
7000
9000
8000
Numberofinfectedpatients
A
Feb 14 Feb 19 Feb 24 Feb 29 March 5 March 10 March 15 March 20
0
5000
10000
15000
20000
25000
35000
30000
Numberofinfectedpatients
Date (2020)
B
Measured
Simulated
Health Policy
2	 www.thelancet.com Published online March 12, 2019 https://doi.org/10.1016/S0140-6736(20)30627-9
Correspondence to:
Prof Andrea Remuzzi,
Department of Management
Information and Production
Engineering, University of
Bergamo, Dalmine 24044, Italy
andrea.remuzzi@unibg.it
important, but it is not enough. At present, our national
health system’s capacity to effectively respond to the needs
of those who are already infected and require admission to
an intensive care unit for ARDS, largely due to SARS-CoV-2
pneumonia, is a matter of grave concern. Specifically, the
percentage of patients admitted to intensive care units
reported daily in Italy, from March 1, up until March 11,
was consistently between 9% and 11% of patients who
were actively infected.
In Italy, we have approximately 5200 beds in intensive
care units. Of those, as of March 11, 1028 are already
devoted to patients with SARS-CoV-2 infection, and in
the near future this number will progressively increase to
the point that thousands of beds will soon be occupied by
patients with COVID-19. Given that the mortality of
patients who are critically ill with SARS-CoV-2 pneu­
monia is high and that the survival time of non-survivors
is 1–2 weeks, the number of people infected in Italy will
probably impose a major strain on critical care facilities
in our hospitals, some of which do not have adequate
resources or staff to deal with this emergency. In the
Lombardy region, despite extraordinary efforts to restrict
the movement of people at the expense of the Italian
economy, we are dealing with an even greater fear—that
the number of patients who present to the emergency
room will become much greater than the system can
cope with. The number of intensive care beds necessary
to give the maximum number of patients the chance to
be treated will reach several thousand, but the exact
number is still a matter of discussion among experts.
Health-care professionals have been working day and
night since Feb 20, and in doing so around 20% (n=350)
of them have become infected, and some have died.
Lombardy is responding to the lack of beds for patients
with COVID-19 by sending patients who need intensive
care but are not infected with COVID-19 to hospitals
outside of the region to contain the virus.
Modelling predictions
We present the following predictions to prepare our
political leaders—those who bear the greatest respon­
sibility for national health systems and the government at
the regional level, as well as local health authorities—for
what is predicted to happen in the days and weeks to
come. They can then implement measures regarding
staff resources and hospital beds to meet the challenges
of this difficult time. Official numbers of infected people
during the COVID-19 virus outbreak in Italy are indicative
of the spread of the infection, and of the challenges that
will be posed to Italian hospitals and, in particular,
intensive care facilities. The number of patients who are
infected has been published daily since Feb 21, 2020. It is
possible to fit the available data for the number of
patients who are actively infected into an exponential
model, as reported in figure 1A. The value of the exponent
can be computed as r=0·225 (1 per day) and is consistent
with the number of infected patients reported by the
Italian Health Ministry. The consistency between the
exponential prediction and the reported data is very close
up until day 17. If the increase in the number of infected
patients follows this trend for the next week, there will be
more than 30 000 patients infected by March 15, as shown
in figure 1B. On the basis of the exponential curve
prediction, and the assumption that the duration of
infection ranges from 15 to 20 days, it is possible to
calculate that the basic reproduction number ranges
from 2·76 to 3·25. This number is similar to that
reported for the initial phase of the infection outbreak
in the city of Wuhan, China3
and slightly higher than 2·2,
as reported by Li and colleagues in a more recent report.4
The number of patients admitted to intensive care
units increased similarly in Italy, with an exponential
trend up until March 8. The best fit of the data reported
by the Italian Ministry for Health can be obtained using
the same exponent that best fits the number of patients
Figure2:Measured and predicted number of patients in intensive care units in Italy using an exponential curve
Panel A shows number of patients in intensive care units in previous days and B shows projections for the coming
days.The dotted line represents the estimated capacity of intensive care beds in Italy.
Feb 27 Feb 29 March 2 March 4 March 6 March 8 March 10
0
100
200
300
400
500
600
700
1000
800
900
Numberofpatientsinintensivecareunits
A
March 16Feb 27 Feb 29 March 2 March 4 March 6 March 8 March 10 March 12 March 14
0
500
1000
1500
2000
2500
3500
3000
Numberofpatientsinintensivecareunits
Date (2020)
B
Measured
Simulated
For the Italian Health Ministry
see http://www.salute.gov.it/
portale/home.html
Health Policy
www.thelancet.com Published online March 12, 2019 https://doi.org/10.1016/S0140-6736(20)30627-9	 3
who are infected, as shown in figure 2A. The data
available up until March 8 show that the trend in the
number of patients who will need admission to intensive
care units will increase substan­tially and relentlessly in
the next few days. We can predict with quite a good
degree of accuracy that this number will push the
national health system to full capacity in a matter of days.
Considering that the number of available beds in
intensive care units in Italy is close to 5200, and assuming
that half of these beds can be used for patients with
COVID-19, the system will be at maximum capacity,
according to this prediction, by March 14, 2020. This
situation is difficult, given that the number of patients
who will need to be admitted to the intensive care unit is
predicted to further increase after that date, as shown in
figure 2B.
At this point, the most important question is whether
the increase in the number of patients who are infected
and those requiring intensive care admittance will
continue to rise exponentially and for how long. If the
change in the slope of the curve does not take place soon,
the clinical and social problems will take on unmanage­
able dimensions, which are expected to have catastrophic
results. The only way we can make such predictions is by
comparing the trends in the data collected in the Hubei
region in China for COVID-19 infection with that for the
Italian population. From the official report of the WHO–
China Joint Mission on Coronavirus Disease 2019,5
it is
possible to derive the cumulative curve of the patients
who are infected from the start of the data series. These
data, as reported in figure 3, show that the initial phase of
the infection outbreak followed the expected exponential
trend, with the same exponent previously calculated for
the number of Italian patients who were infected. Starting
Jan 7, the cumulative number of patients who were
infected started to diverge from the exponential trend
20 days later. If the Italian outbreak follows a similar
trend to that in China, we can suggest that the number of
newly infected patients might start to decrease within
3–4 days from March 11. Similarly, we can foresee that the
cumulative curve of patients who are infected will peak
30 days later, with the maximum load for clinical facilities
for the treatment of these patients foreseen for that
period.
Discussion
The most difficult prediction is the maximum number of
infected patients that will be reached in Italy and, most
importantly, the maximum number of patients who will
require intensive care unit admission. This prediction is of
crucial importance to plan for new facilities in Italian
hospitals and to calculate the time period in which they
need to be available. On the basis that the region of Hubei
in China has a slightly smaller population than Italy
(approximately 50 million in Hubei and 60 million in
Italy), we tentatively assumed that the trend for the
maximum number of patients who are actively infected
would be similar in the two territories. In doing so, we
cannot overlook the fact that the effect of travel restric­tions
on the spread of the COVID-19 outbreak and the
extraordinary community measures taken within and
outside of Wuhan are unlikely to be replicated elsewhere.
Moreover, the current approach to these patients in
Lombardy implies non-pharmacological and pharma­
cological interventions, including antiretroviral medi­
cation, which might be different from the Wuhan outbreak,
and could distort the calculation. We also realise that there
is heterogeneity in the transmission dynamics between
the city of Wuhan and elsewhere in the province, where
the number of people who are infected remains lower.
Therefore, it might not be unrealistic to assume that what
is going to happen in Italy soon might mirror what
happened in Hubei. Of course, it would have been more
appropriate to directly compare Greater Wuhan (19 million
people) with the region of Lombardy (9 million people),
the most seriously affected region in Italy at the moment,
but such data are not available.6
We do not currently have
additional evidence we can take into consideration to make
more robust assumptions regarding the exact number of
patients who will be infected in the future days or weeks.
On the basis of the available data,5
the number of infected
patients reached approximately 38 000 at the end of
February, 2020, in the Hubei region, when the number of
new cases decreased to almost zero. Given that so far the
percentage of patients requiring ARDS treatment is close
to 10% for patients who are actively infected, at least in
Lombardy, we can assume that we will need approximately
4000 beds in intensive care units during the worst period
of infection, which is expected to occur in about 4 weeks
from March 11. This is challenging for Italy, as there are
now just over 5200 intensive care beds in total. The aim
now is to increase this number to safely meet urgent future
Figure 3: Fitting of cumulative curve of measured infected patients in Hubei,China, with an exponential curve
The dotted line represents the timepoint of the infection outbreak in Italy. It is expected that the number of
cumulative patients who are infected will start to deviate from the exponential low in 3–4 days.The plateau of the
cumulative curve will be reached just over 30 days from March 11, 2020.
Jan 5 Jan 10 Jan 15 Jan 20 Jan 25 Jan 30 Feb 4 Feb 9 Feb 14 Feb 19 Feb 24
0
10000
20000
30000
40000
50000
60000
Numberofinfectedpatients
Date (2020)
Measured
Simulated
Health Policy
4	 www.thelancet.com Published online March 12, 2019 https://doi.org/10.1016/S0140-6736(20)30627-9
needs. According to our prediction, we have only a few
weeks to achieve this goal in terms of procuring personnel,
technical equipment, and materials. These considerations
might also apply to other European countries that could
have similar numbers of patients infected and similar
needs regarding intensive care admissions.
Since 1978, Italy has had the privilege of having a
national health system (Servizio Sanitario Nazionale),
which was reshaped from 1992–93. Its principles and
organisation derive from the British National Health
Service model, and it is based on three fundamental
principles. The first principle is universality—all citizens
have an equal right to access services provided by the
national health system. The second is solidarity—every
citizen contributes to financing the national health service
based on their means, through progressive taxation. The
third is uniformity—the quality of the services provided
by the national health service to all citizens in all regions
must be uniform. All individuals are supposed to pay
for it as taxpayers, each person giving a little to receive a
lot in return, if they become unwell.
Conclusion
In theory, we are in a better position than many other
countries to react to the current outbreak. However, an
aggressive approach needs to be taken with patients
who are critically ill with SARS-CoV-2, often including
ventilatory support. The system’s capacity to respond
to changing circumstances has been under enormous
pressure, at least in the Lombardy region, where
two clusters have already emerged since Feb 21. We
predict that if the exponential trend continues for the
next few days, more than 2500 hospital beds for patients
in intensive care units will be needed in only 1 week to
treat ARDS caused by SARS-CoV-2-pneumonia in Italy.
In the meantime, the government is preparing to pass
legislation that will enable the health service to hire
20 000 more doctors and nurses and to provide 5000 more
ventilators to Italian hospitals. These measures are a step
in the right direction, but our model tells us that they
need to be implemented urgently, in a matter of days.
Otherwise, a substantial number of unnecessary deaths
will become inevitable. Intensive care specialists are
already considering denying life-saving care to the sickest
and giving priority to those patients most likely to survive
when deciding who to provide ventilation to. This attitude
has already been criticised by the current President of the
Italian Comitato di Bioetica who, in a recent declaration
to lay press stated that the Constitution recognises the
right of every individual to receive all necessary health
care. They might not recognise that the reality is that
intensive care wards are overflowing with patients and
that COVID-19 is not a benign disease. Our doctors and
nurses are modern heroes in an unexpected war against
a difficult enemy. In the near future, they will have no
choice. They will have to follow the same rules that
health-care workers are left with in conflict and disaster
zones. We hope that the present analysis will help
political leaders and health authorities to move as quickly
as they can to ensure that there are enough resources,
including personnel, hospital beds, and intensive care
facilities, for what is going to happen in the next few days
and weeks. Finally, our analysis tends to suggest that
measures to reduce transmission should certainly be
implemented, as our government did on March 9, by
inhibiting people’s movement and social activities,
unless strictly required. Rather than revising the
Schengen visa-free zone, the most effective way to
contain this viral outbreak in European countries is
probably to avoid close contact at the individual level and
social meetings in each country.
Contributors
AR was responsible for data analysis and statistics, and writing of the
manuscript. GR was responsible for data analysis and writing of the
manuscript.
Declarations of interest
We declare no competing interests.
Acknowledgments
We thank Kerstin Mierke for writing assistance.
References
1	 Callaway E. Time to use the p-word? Coronavirus enter dangerous
new phase. Nature 2020; 579: 12.
2	 The Economist. Tourism flows and death rates suggest covid-19 is
being under-reported. 2020. https://www.economist.com/graphic-
detail/2020/03/07/tourism-flows-and-death-rates-suggest-covid-19-
is-being-under-reported (accessed March 11, 2020).
3	 Leung G, Wuhttps J. Real-time nowcast and forecast on the extent
of the Wuhan CoV outbreak, domestic and international spread.
2020. https://www.med.hku.hk/f/news/3549/7418/Wuhan-
coronavirus-outbreak_AN-UPDATE_20200127.pdf (accessed
March 11, 2020).
4	 Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan,
China, of novel coronavirus-infected pneumonia. N Engl J Med
2020; published online Jan 29. DOI:10.1056/NEJMoa2001316.
5	 Joint Mission. Report of the WHO-China Joint Mission on
Coronavirus Disease 2019 (COVID-19). 2020. https://www.who.int/
docs/default-source/coronaviruse/who-china-joint-mission-on-
covid-19-final-report.pdf (accessed March 11, 2020).
6	 Johns Hopkins Center for Systems Science and Engineering.
Coronavirus COVID-19 Global Cases. 2020. https://systems.jhu.
edu/research/public-health/ncov/ (accessed March 11, 2020).
© 2020 Elsevier Ltd. All rights reserved.

More Related Content

What's hot

COVID-19: towards controlling of a pandemic
COVID-19: towards controlling of a pandemicCOVID-19: towards controlling of a pandemic
COVID-19: towards controlling of a pandemic
Valentina Corona
 
Psychiatry Research
Psychiatry ResearchPsychiatry Research
Psychiatry Research
Valentina Corona
 
Fair Allocation of Scarce Medical Resources in the Time of Covid-19
Fair Allocation of Scarce Medical Resources in the Time of Covid-19Fair Allocation of Scarce Medical Resources in the Time of Covid-19
Fair Allocation of Scarce Medical Resources in the Time of Covid-19
Valentina Corona
 
Covid 19 report commissione salute Lincei
Covid 19 report commissione salute LinceiCovid 19 report commissione salute Lincei
Covid 19 report commissione salute Lincei
Valentina Corona
 
Reduction of hospitalizations
Reduction of hospitalizationsReduction of hospitalizations
Reduction of hospitalizations
Francesco Megna
 
Offline COVID-19 and the NHS " a national scandal"
Offline COVID-19 and the NHS " a national scandal"Offline COVID-19 and the NHS " a national scandal"
Offline COVID-19 and the NHS " a national scandal"
Valentina Corona
 
Rational use of face masks in the COVID-19 pandemic
Rational use of face masks in the COVID-19 pandemicRational use of face masks in the COVID-19 pandemic
Rational use of face masks in the COVID-19 pandemic
Valentina Corona
 
Aerosol and Surface Stability of SARS-CoV-2
Aerosol and Surface Stability of SARS-CoV-2Aerosol and Surface Stability of SARS-CoV-2
Aerosol and Surface Stability of SARS-CoV-2
Valentina Corona
 
Covid 19 emergencia Dr. Freddy Flores Malpartida
Covid 19 emergencia Dr. Freddy Flores MalpartidaCovid 19 emergencia Dr. Freddy Flores Malpartida
Covid 19 emergencia Dr. Freddy Flores Malpartida
Freddy Flores Malpartida
 
Undertstanding unreported cases in the 2019-nCov epidemic
Undertstanding unreported cases in the 2019-nCov epidemicUndertstanding unreported cases in the 2019-nCov epidemic
Undertstanding unreported cases in the 2019-nCov epidemic
Valentina Corona
 
Novel Coronavirus an Old Lessons
Novel Coronavirus an Old Lessons Novel Coronavirus an Old Lessons
Novel Coronavirus an Old Lessons
Valentina Corona
 
Covid reference01 book Dr. Freddy Flores Malpartida
Covid reference01 book Dr. Freddy Flores MalpartidaCovid reference01 book Dr. Freddy Flores Malpartida
Covid reference01 book Dr. Freddy Flores Malpartida
Freddy Flores Malpartida
 
Stopping the Spread of COVID-19
Stopping the Spread of COVID-19Stopping the Spread of COVID-19
Stopping the Spread of COVID-19
Valentina Corona
 
We signed up for this!
We signed up for this!We signed up for this!
We signed up for this!
Valentina Corona
 
Similarities and Differences between the New Coronavirus Infectious 2019 COVI...
Similarities and Differences between the New Coronavirus Infectious 2019 COVI...Similarities and Differences between the New Coronavirus Infectious 2019 COVI...
Similarities and Differences between the New Coronavirus Infectious 2019 COVI...
ijtsrd
 
Rockefeller vaccination plan
Rockefeller vaccination planRockefeller vaccination plan
Rockefeller vaccination plan
Cultura Arte Sociedad (Cuarso)
 
Yale - Tulane - Sacred Heart ESF-8 US Special Report - COVID-19 Nursing Hom...
Yale - Tulane - Sacred Heart  ESF-8 US Special Report  - COVID-19 Nursing Hom...Yale - Tulane - Sacred Heart  ESF-8 US Special Report  - COVID-19 Nursing Hom...
Yale - Tulane - Sacred Heart ESF-8 US Special Report - COVID-19 Nursing Hom...
Yale -Tulane ESF-8 Planning and Response Network
 
Yale- Tulane-Sacred Heart ESF-8 Special US Report - COVID-19 5-1-20
Yale- Tulane-Sacred Heart ESF-8 Special US Report - COVID-19  5-1-20Yale- Tulane-Sacred Heart ESF-8 Special US Report - COVID-19  5-1-20
Yale- Tulane-Sacred Heart ESF-8 Special US Report - COVID-19 5-1-20
Yale -Tulane ESF-8 Planning and Response Network
 
Yale-Tulane-Sacred Heart- ESF-8 Special Global Report - COVID-19 4-27-20
Yale-Tulane-Sacred Heart- ESF-8 Special  Global Report - COVID-19 4-27-20 Yale-Tulane-Sacred Heart- ESF-8 Special  Global Report - COVID-19 4-27-20
Yale-Tulane-Sacred Heart- ESF-8 Special Global Report - COVID-19 4-27-20
Yale -Tulane ESF-8 Planning and Response Network
 
Yale ESF-8 Special Report COVID-19 3-26-2020
Yale ESF-8 Special Report COVID-19 3-26-2020Yale ESF-8 Special Report COVID-19 3-26-2020
Yale ESF-8 Special Report COVID-19 3-26-2020
Yale -Tulane ESF-8 Planning and Response Network
 

What's hot (20)

COVID-19: towards controlling of a pandemic
COVID-19: towards controlling of a pandemicCOVID-19: towards controlling of a pandemic
COVID-19: towards controlling of a pandemic
 
Psychiatry Research
Psychiatry ResearchPsychiatry Research
Psychiatry Research
 
Fair Allocation of Scarce Medical Resources in the Time of Covid-19
Fair Allocation of Scarce Medical Resources in the Time of Covid-19Fair Allocation of Scarce Medical Resources in the Time of Covid-19
Fair Allocation of Scarce Medical Resources in the Time of Covid-19
 
Covid 19 report commissione salute Lincei
Covid 19 report commissione salute LinceiCovid 19 report commissione salute Lincei
Covid 19 report commissione salute Lincei
 
Reduction of hospitalizations
Reduction of hospitalizationsReduction of hospitalizations
Reduction of hospitalizations
 
Offline COVID-19 and the NHS " a national scandal"
Offline COVID-19 and the NHS " a national scandal"Offline COVID-19 and the NHS " a national scandal"
Offline COVID-19 and the NHS " a national scandal"
 
Rational use of face masks in the COVID-19 pandemic
Rational use of face masks in the COVID-19 pandemicRational use of face masks in the COVID-19 pandemic
Rational use of face masks in the COVID-19 pandemic
 
Aerosol and Surface Stability of SARS-CoV-2
Aerosol and Surface Stability of SARS-CoV-2Aerosol and Surface Stability of SARS-CoV-2
Aerosol and Surface Stability of SARS-CoV-2
 
Covid 19 emergencia Dr. Freddy Flores Malpartida
Covid 19 emergencia Dr. Freddy Flores MalpartidaCovid 19 emergencia Dr. Freddy Flores Malpartida
Covid 19 emergencia Dr. Freddy Flores Malpartida
 
Undertstanding unreported cases in the 2019-nCov epidemic
Undertstanding unreported cases in the 2019-nCov epidemicUndertstanding unreported cases in the 2019-nCov epidemic
Undertstanding unreported cases in the 2019-nCov epidemic
 
Novel Coronavirus an Old Lessons
Novel Coronavirus an Old Lessons Novel Coronavirus an Old Lessons
Novel Coronavirus an Old Lessons
 
Covid reference01 book Dr. Freddy Flores Malpartida
Covid reference01 book Dr. Freddy Flores MalpartidaCovid reference01 book Dr. Freddy Flores Malpartida
Covid reference01 book Dr. Freddy Flores Malpartida
 
Stopping the Spread of COVID-19
Stopping the Spread of COVID-19Stopping the Spread of COVID-19
Stopping the Spread of COVID-19
 
We signed up for this!
We signed up for this!We signed up for this!
We signed up for this!
 
Similarities and Differences between the New Coronavirus Infectious 2019 COVI...
Similarities and Differences between the New Coronavirus Infectious 2019 COVI...Similarities and Differences between the New Coronavirus Infectious 2019 COVI...
Similarities and Differences between the New Coronavirus Infectious 2019 COVI...
 
Rockefeller vaccination plan
Rockefeller vaccination planRockefeller vaccination plan
Rockefeller vaccination plan
 
Yale - Tulane - Sacred Heart ESF-8 US Special Report - COVID-19 Nursing Hom...
Yale - Tulane - Sacred Heart  ESF-8 US Special Report  - COVID-19 Nursing Hom...Yale - Tulane - Sacred Heart  ESF-8 US Special Report  - COVID-19 Nursing Hom...
Yale - Tulane - Sacred Heart ESF-8 US Special Report - COVID-19 Nursing Hom...
 
Yale- Tulane-Sacred Heart ESF-8 Special US Report - COVID-19 5-1-20
Yale- Tulane-Sacred Heart ESF-8 Special US Report - COVID-19  5-1-20Yale- Tulane-Sacred Heart ESF-8 Special US Report - COVID-19  5-1-20
Yale- Tulane-Sacred Heart ESF-8 Special US Report - COVID-19 5-1-20
 
Yale-Tulane-Sacred Heart- ESF-8 Special Global Report - COVID-19 4-27-20
Yale-Tulane-Sacred Heart- ESF-8 Special  Global Report - COVID-19 4-27-20 Yale-Tulane-Sacred Heart- ESF-8 Special  Global Report - COVID-19 4-27-20
Yale-Tulane-Sacred Heart- ESF-8 Special Global Report - COVID-19 4-27-20
 
Yale ESF-8 Special Report COVID-19 3-26-2020
Yale ESF-8 Special Report COVID-19 3-26-2020Yale ESF-8 Special Report COVID-19 3-26-2020
Yale ESF-8 Special Report COVID-19 3-26-2020
 

Similar to COVID-19 and Italy: what next?

Cidrap covid19-viewpoint-part1
Cidrap covid19-viewpoint-part1Cidrap covid19-viewpoint-part1
Cidrap covid19-viewpoint-part1
LanaSokoljva
 
Coronavirus COVID-19: Facts and Insights
Coronavirus COVID-19: Facts and InsightsCoronavirus COVID-19: Facts and Insights
Coronavirus COVID-19: Facts and Insights
Harsha MV
 
Final exam english ii reynaldi 20160700011
Final exam english ii reynaldi 20160700011Final exam english ii reynaldi 20160700011
Final exam english ii reynaldi 20160700011
Reynaldi18
 
Co v trends
Co v trendsCo v trends
Co v trends
Mumbaikar Le
 
Covid tto reino_unido Dr. Freddy Flores Malpartida
Covid tto reino_unido Dr. Freddy Flores MalpartidaCovid tto reino_unido Dr. Freddy Flores Malpartida
Covid tto reino_unido Dr. Freddy Flores Malpartida
Freddy Flores Malpartida
 
Abstract congress covid 19.docx30
Abstract congress covid 19.docx30Abstract congress covid 19.docx30
Abstract congress covid 19.docx30
Enida Xhaferi
 
Emergency management .docx
Emergency management                                              .docxEmergency management                                              .docx
Emergency management .docx
christinemaritza
 
University of Bern - adjusted cfr covid-19
University of Bern -  adjusted cfr covid-19University of Bern -  adjusted cfr covid-19
University of Bern - adjusted cfr covid-19
Federico Tassara, ASA
 
Bartoszek2020 article are_officialconfirmedcasesandfa
Bartoszek2020 article are_officialconfirmedcasesandfaBartoszek2020 article are_officialconfirmedcasesandfa
Bartoszek2020 article are_officialconfirmedcasesandfa
MAHMOUD_HAWK
 
1 s2.0-s2214109 x21000814-main (1)
1 s2.0-s2214109 x21000814-main (1)1 s2.0-s2214109 x21000814-main (1)
1 s2.0-s2214109 x21000814-main (1)
Luís Carlos Nunes
 
Prévisions de Research Luxembourg
Prévisions de Research LuxembourgPrévisions de Research Luxembourg
Prévisions de Research Luxembourg
Paperjam_redaction
 
Estimating the burden of SARS-CoV-2 in France
Estimating the burden of SARS-CoV-2 in FranceEstimating the burden of SARS-CoV-2 in France
Estimating the burden of SARS-CoV-2 in France
Guy Boulianne
 
IRJET - Technology and COVID - 19
IRJET -  	  Technology and COVID - 19IRJET -  	  Technology and COVID - 19
IRJET - Technology and COVID - 19
IRJET Journal
 
Update for second-wave_20201016
Update for second-wave_20201016Update for second-wave_20201016
Update for second-wave_20201016
Paperjam_redaction
 
Ruan2020 likelihood of survival of coronavirus disease 2019
Ruan2020   likelihood of survival of coronavirus disease 2019Ruan2020   likelihood of survival of coronavirus disease 2019
Ruan2020 likelihood of survival of coronavirus disease 2019
Nilda Vllacres
 
Informe de Fedea
Informe de FedeaInforme de Fedea
Informe de Fedea
20minutos
 
Impact of COVID-19 caronavirus on poverty in Pakistan: a case study of Sindh
Impact of COVID-19 caronavirus on poverty in Pakistan: a case study of SindhImpact of COVID-19 caronavirus on poverty in Pakistan: a case study of Sindh
Impact of COVID-19 caronavirus on poverty in Pakistan: a case study of Sindh
SubmissionResearchpa
 
Research Correspondence
Research CorrespondenceResearch Correspondence
Research Correspondence
Valentina Corona
 

Similar to COVID-19 and Italy: what next? (20)

vaksin.pdf
vaksin.pdfvaksin.pdf
vaksin.pdf
 
Cidrap covid19-viewpoint-part1
Cidrap covid19-viewpoint-part1Cidrap covid19-viewpoint-part1
Cidrap covid19-viewpoint-part1
 
Coronavirus COVID-19: Facts and Insights
Coronavirus COVID-19: Facts and InsightsCoronavirus COVID-19: Facts and Insights
Coronavirus COVID-19: Facts and Insights
 
Final exam english ii reynaldi 20160700011
Final exam english ii reynaldi 20160700011Final exam english ii reynaldi 20160700011
Final exam english ii reynaldi 20160700011
 
Co v trends
Co v trendsCo v trends
Co v trends
 
Covid tto reino_unido Dr. Freddy Flores Malpartida
Covid tto reino_unido Dr. Freddy Flores MalpartidaCovid tto reino_unido Dr. Freddy Flores Malpartida
Covid tto reino_unido Dr. Freddy Flores Malpartida
 
Abstract congress covid 19.docx30
Abstract congress covid 19.docx30Abstract congress covid 19.docx30
Abstract congress covid 19.docx30
 
Emergency management .docx
Emergency management                                              .docxEmergency management                                              .docx
Emergency management .docx
 
University of Bern - adjusted cfr covid-19
University of Bern -  adjusted cfr covid-19University of Bern -  adjusted cfr covid-19
University of Bern - adjusted cfr covid-19
 
Bartoszek2020 article are_officialconfirmedcasesandfa
Bartoszek2020 article are_officialconfirmedcasesandfaBartoszek2020 article are_officialconfirmedcasesandfa
Bartoszek2020 article are_officialconfirmedcasesandfa
 
1 s2.0-s2214109 x21000814-main (1)
1 s2.0-s2214109 x21000814-main (1)1 s2.0-s2214109 x21000814-main (1)
1 s2.0-s2214109 x21000814-main (1)
 
Prévisions de Research Luxembourg
Prévisions de Research LuxembourgPrévisions de Research Luxembourg
Prévisions de Research Luxembourg
 
Estimating the burden of SARS-CoV-2 in France
Estimating the burden of SARS-CoV-2 in FranceEstimating the burden of SARS-CoV-2 in France
Estimating the burden of SARS-CoV-2 in France
 
IRJET - Technology and COVID - 19
IRJET -  	  Technology and COVID - 19IRJET -  	  Technology and COVID - 19
IRJET - Technology and COVID - 19
 
Update for second-wave_20201016
Update for second-wave_20201016Update for second-wave_20201016
Update for second-wave_20201016
 
Ruan2020 likelihood of survival of coronavirus disease 2019
Ruan2020   likelihood of survival of coronavirus disease 2019Ruan2020   likelihood of survival of coronavirus disease 2019
Ruan2020 likelihood of survival of coronavirus disease 2019
 
Main
MainMain
Main
 
Informe de Fedea
Informe de FedeaInforme de Fedea
Informe de Fedea
 
Impact of COVID-19 caronavirus on poverty in Pakistan: a case study of Sindh
Impact of COVID-19 caronavirus on poverty in Pakistan: a case study of SindhImpact of COVID-19 caronavirus on poverty in Pakistan: a case study of Sindh
Impact of COVID-19 caronavirus on poverty in Pakistan: a case study of Sindh
 
Research Correspondence
Research CorrespondenceResearch Correspondence
Research Correspondence
 

More from Valentina Corona

Walter Artibani
Walter ArtibaniWalter Artibani
Walter Artibani
Valentina Corona
 
Progetto strategico SIU Oltre
Progetto strategico SIU OltreProgetto strategico SIU Oltre
Progetto strategico SIU Oltre
Valentina Corona
 
Telehealth in Urology: A Systematic Review of the Literature.
Telehealth in Urology: A Systematic Review of the Literature.Telehealth in Urology: A Systematic Review of the Literature.
Telehealth in Urology: A Systematic Review of the Literature.
Valentina Corona
 
Remdesivir for the Treatment of Covid-19
Remdesivir for the Treatment of Covid-19Remdesivir for the Treatment of Covid-19
Remdesivir for the Treatment of Covid-19
Valentina Corona
 
Avoidng disruption of timely surgical management of genitourinary cancers ...
Avoidng disruption of timely surgical management of genitourinary cancers ...Avoidng disruption of timely surgical management of genitourinary cancers ...
Avoidng disruption of timely surgical management of genitourinary cancers ...
Valentina Corona
 
Avoiding disruption of surgical treatment of genitourinary cancers...
Avoiding disruption of surgical treatment of genitourinary cancers...Avoiding disruption of surgical treatment of genitourinary cancers...
Avoiding disruption of surgical treatment of genitourinary cancers...
Valentina Corona
 
A systematic review on COVID-1: urological manifestations...
A systematic review on COVID-1: urological manifestations...A systematic review on COVID-1: urological manifestations...
A systematic review on COVID-1: urological manifestations...
Valentina Corona
 
Urology in the time of Coronavirus: Reduced Acmes to Urgent and Emergent Care...
Urology in the time of Coronavirus: Reduced Acmes to Urgent and Emergent Care...Urology in the time of Coronavirus: Reduced Acmes to Urgent and Emergent Care...
Urology in the time of Coronavirus: Reduced Acmes to Urgent and Emergent Care...
Valentina Corona
 
Accessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Pr...
Accessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Pr...Accessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Pr...
Accessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Pr...
Valentina Corona
 
A Global Survey on the Impact of COVID-19 on Urological Services
A Global Survey on the Impact of COVID-19 on Urological ServicesA Global Survey on the Impact of COVID-19 on Urological Services
A Global Survey on the Impact of COVID-19 on Urological Services
Valentina Corona
 
Since January Elsevier has created a COVID-19 resource center with...
Since January Elsevier has created a COVID-19 resource center with...Since January Elsevier has created a COVID-19 resource center with...
Since January Elsevier has created a COVID-19 resource center with...
Valentina Corona
 
Since January Elsevier has created a COVID-19 resource center with...
Since January Elsevier has created a COVID-19 resource center with...Since January Elsevier has created a COVID-19 resource center with...
Since January Elsevier has created a COVID-19 resource center with...
Valentina Corona
 
Androgen-deprivation therapies for prostate cancer and risk of infection by S...
Androgen-deprivation therapies for prostate cancer and risk of infection by S...Androgen-deprivation therapies for prostate cancer and risk of infection by S...
Androgen-deprivation therapies for prostate cancer and risk of infection by S...
Valentina Corona
 
Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces
Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on SurfacesSimulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces
Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces
Valentina Corona
 
Hydroxychloroquine or chloroquine with or without a macrolide for treatment o...
Hydroxychloroquine or chloroquine with or without a macrolide for treatment o...Hydroxychloroquine or chloroquine with or without a macrolide for treatment o...
Hydroxychloroquine or chloroquine with or without a macrolide for treatment o...
Valentina Corona
 
Chloroquine or hydroxychloroquine for Covid-19: why might they be hazardous?
Chloroquine or hydroxychloroquine for Covid-19: why might they be hazardous?Chloroquine or hydroxychloroquine for Covid-19: why might they be hazardous?
Chloroquine or hydroxychloroquine for Covid-19: why might they be hazardous?
Valentina Corona
 
Pulmonary Vascular Endotheliatis Thrombosis, and Angiogenesis in Covid-19
Pulmonary Vascular Endotheliatis Thrombosis, and Angiogenesis in Covid-19Pulmonary Vascular Endotheliatis Thrombosis, and Angiogenesis in Covid-19
Pulmonary Vascular Endotheliatis Thrombosis, and Angiogenesis in Covid-19
Valentina Corona
 
Assessment of Deaths from Covid 19 and from Seasonal Influenza
Assessment of Deaths from Covid 19 and from Seasonal Influenza Assessment of Deaths from Covid 19 and from Seasonal Influenza
Assessment of Deaths from Covid 19 and from Seasonal Influenza
Valentina Corona
 
Protocollo biopsie prostatiche fase 2
Protocollo  biopsie prostatiche fase 2Protocollo  biopsie prostatiche fase 2
Protocollo biopsie prostatiche fase 2
Valentina Corona
 
Gender Differences in Patient with COVID 19
Gender Differences in Patient with COVID 19Gender Differences in Patient with COVID 19
Gender Differences in Patient with COVID 19
Valentina Corona
 

More from Valentina Corona (20)

Walter Artibani
Walter ArtibaniWalter Artibani
Walter Artibani
 
Progetto strategico SIU Oltre
Progetto strategico SIU OltreProgetto strategico SIU Oltre
Progetto strategico SIU Oltre
 
Telehealth in Urology: A Systematic Review of the Literature.
Telehealth in Urology: A Systematic Review of the Literature.Telehealth in Urology: A Systematic Review of the Literature.
Telehealth in Urology: A Systematic Review of the Literature.
 
Remdesivir for the Treatment of Covid-19
Remdesivir for the Treatment of Covid-19Remdesivir for the Treatment of Covid-19
Remdesivir for the Treatment of Covid-19
 
Avoidng disruption of timely surgical management of genitourinary cancers ...
Avoidng disruption of timely surgical management of genitourinary cancers ...Avoidng disruption of timely surgical management of genitourinary cancers ...
Avoidng disruption of timely surgical management of genitourinary cancers ...
 
Avoiding disruption of surgical treatment of genitourinary cancers...
Avoiding disruption of surgical treatment of genitourinary cancers...Avoiding disruption of surgical treatment of genitourinary cancers...
Avoiding disruption of surgical treatment of genitourinary cancers...
 
A systematic review on COVID-1: urological manifestations...
A systematic review on COVID-1: urological manifestations...A systematic review on COVID-1: urological manifestations...
A systematic review on COVID-1: urological manifestations...
 
Urology in the time of Coronavirus: Reduced Acmes to Urgent and Emergent Care...
Urology in the time of Coronavirus: Reduced Acmes to Urgent and Emergent Care...Urology in the time of Coronavirus: Reduced Acmes to Urgent and Emergent Care...
Urology in the time of Coronavirus: Reduced Acmes to Urgent and Emergent Care...
 
Accessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Pr...
Accessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Pr...Accessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Pr...
Accessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Pr...
 
A Global Survey on the Impact of COVID-19 on Urological Services
A Global Survey on the Impact of COVID-19 on Urological ServicesA Global Survey on the Impact of COVID-19 on Urological Services
A Global Survey on the Impact of COVID-19 on Urological Services
 
Since January Elsevier has created a COVID-19 resource center with...
Since January Elsevier has created a COVID-19 resource center with...Since January Elsevier has created a COVID-19 resource center with...
Since January Elsevier has created a COVID-19 resource center with...
 
Since January Elsevier has created a COVID-19 resource center with...
Since January Elsevier has created a COVID-19 resource center with...Since January Elsevier has created a COVID-19 resource center with...
Since January Elsevier has created a COVID-19 resource center with...
 
Androgen-deprivation therapies for prostate cancer and risk of infection by S...
Androgen-deprivation therapies for prostate cancer and risk of infection by S...Androgen-deprivation therapies for prostate cancer and risk of infection by S...
Androgen-deprivation therapies for prostate cancer and risk of infection by S...
 
Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces
Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on SurfacesSimulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces
Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces
 
Hydroxychloroquine or chloroquine with or without a macrolide for treatment o...
Hydroxychloroquine or chloroquine with or without a macrolide for treatment o...Hydroxychloroquine or chloroquine with or without a macrolide for treatment o...
Hydroxychloroquine or chloroquine with or without a macrolide for treatment o...
 
Chloroquine or hydroxychloroquine for Covid-19: why might they be hazardous?
Chloroquine or hydroxychloroquine for Covid-19: why might they be hazardous?Chloroquine or hydroxychloroquine for Covid-19: why might they be hazardous?
Chloroquine or hydroxychloroquine for Covid-19: why might they be hazardous?
 
Pulmonary Vascular Endotheliatis Thrombosis, and Angiogenesis in Covid-19
Pulmonary Vascular Endotheliatis Thrombosis, and Angiogenesis in Covid-19Pulmonary Vascular Endotheliatis Thrombosis, and Angiogenesis in Covid-19
Pulmonary Vascular Endotheliatis Thrombosis, and Angiogenesis in Covid-19
 
Assessment of Deaths from Covid 19 and from Seasonal Influenza
Assessment of Deaths from Covid 19 and from Seasonal Influenza Assessment of Deaths from Covid 19 and from Seasonal Influenza
Assessment of Deaths from Covid 19 and from Seasonal Influenza
 
Protocollo biopsie prostatiche fase 2
Protocollo  biopsie prostatiche fase 2Protocollo  biopsie prostatiche fase 2
Protocollo biopsie prostatiche fase 2
 
Gender Differences in Patient with COVID 19
Gender Differences in Patient with COVID 19Gender Differences in Patient with COVID 19
Gender Differences in Patient with COVID 19
 

Recently uploaded

micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 

Recently uploaded (20)

micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 

COVID-19 and Italy: what next?

  • 1. Health Policy www.thelancet.com Published online March 12, 2019 https://doi.org/10.1016/S0140-6736(20)30627-9 1 COVID-19 and Italy: what next? Andrea Remuzzi, Giuseppe Remuzzi The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already taken on pandemic proportions, affecting over 100 countries in a matter of weeks. A global response to prepare health systems worldwide is imperative. Although containment measures in China have reduced new cases by more than 90%, this reduction is not the case elsewhere, and Italy has been particularly affected. There is now grave concern regarding the Italian national health system’s capacity to effectively respond to the needs of patients who are infected and require intensive care for SARS-CoV-2 pneumonia. The percentage of patients in intensive care reported daily in Italy between March 1 and March 11, 2020, has consistently been between 9% and 11% of patients who are actively infected. The number of patients infected since Feb 21 in Italy closely follows an exponential trend. If this trend continues for 1 more week, there will be 30 000 infected patients. Intensive care units will then be at maximum capacity; up to 4000 hospital beds will be needed by mid-April, 2020. Our analysis might help political leaders and health authorities to allocate enough resources, including personnel, beds, and intensive care facilities, to manage the situation in the next few days and weeks. If the Italian outbreak follows a similar trend as in Hubei province, China, the number of newly infected patients could start to decrease within 3–4 days, departing from the exponential trend. However, this cannot currently be predicted because of differences between social distancing measures and the capacity to quickly build dedicated facilities in China. Introduction According to Nature, the spread of coronavirus disease 2019 (COVID-19) is becoming unstoppable and has already reached the necessary epidemiological criteria for it to be declared a pandemic, having infected more than 100 000 people in 100 countries.1 Therefore, a coordinated global response is desperately needed to prepare health systems to meet this unprecedented challenge. Countries that have been unfortunate enough to have been exposed to this disease already have, paradoxically, very valuable lessons to pass on. Although the containment measures implemented in China have—at least for the moment— reduced new cases by more than 90%, this reduction is not the case in other countries, including Italy and Iran.2 Italy has had 12 462 confirmed cases according to the Istituto Superiore di Sanità as of March 11, and 827 deaths. Only China has recorded more deaths due to this COVID-19 outbreak. The mean age of those who died in Italy was 81 years and more than two-thirds of these patients had diabetes, cardiovascular diseases, or cancer, or were former smokers. It is therefore true that these patients had underlying health conditions, but it is also worth noting that they had acute respiratory distress syndrome (ARDS) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia, needed respiratory support, and would not have died otherwise. Of the patients who died, 42·2% were aged 80–89 years, 32·4% were aged 70–79 years, 8·4% were aged 60–69 years, and 2·8% were aged 50–59 years (those aged >90 years made up 14·1%). The male to female ratio is 80% to 20% with an older median age for women (83·4 years for women vs 79·9 years for men). On March 8, 2020, the Italian Government imple­mented extraordinary measures to limit viral transmission—in­ cluding restricting movement in the region of Lombardy— that intended to minimise the likelihood that people who are not infected come into contact with people who are infected. This decision is certainly courageous and Published Online March 12, 2020 https://doi.org/10.1016/ S0140-6736(20)30627-9 Department of Management Information and Production Engineering, University of Bergamo, Dalmine, Italy (Prof A Remuzzi EngD); and Istituto di Ricerche Farmacologiche Mario Negri IRCCS (Prof G Remuzzi MD) Figure 1: Measured and predicted number of patients reported to be infected in Italy using an exponential curve PanelA shows number of infections in previous days and B shows projections forthe coming days. Feb 19 Feb 21 Feb 23 Feb 25 Feb 27 Feb 29 March 2 March 4 March 6 March 8 March 10 0 1000 2000 3000 4000 5000 6000 7000 9000 8000 Numberofinfectedpatients A Feb 14 Feb 19 Feb 24 Feb 29 March 5 March 10 March 15 March 20 0 5000 10000 15000 20000 25000 35000 30000 Numberofinfectedpatients Date (2020) B Measured Simulated
  • 2. Health Policy 2 www.thelancet.com Published online March 12, 2019 https://doi.org/10.1016/S0140-6736(20)30627-9 Correspondence to: Prof Andrea Remuzzi, Department of Management Information and Production Engineering, University of Bergamo, Dalmine 24044, Italy andrea.remuzzi@unibg.it important, but it is not enough. At present, our national health system’s capacity to effectively respond to the needs of those who are already infected and require admission to an intensive care unit for ARDS, largely due to SARS-CoV-2 pneumonia, is a matter of grave concern. Specifically, the percentage of patients admitted to intensive care units reported daily in Italy, from March 1, up until March 11, was consistently between 9% and 11% of patients who were actively infected. In Italy, we have approximately 5200 beds in intensive care units. Of those, as of March 11, 1028 are already devoted to patients with SARS-CoV-2 infection, and in the near future this number will progressively increase to the point that thousands of beds will soon be occupied by patients with COVID-19. Given that the mortality of patients who are critically ill with SARS-CoV-2 pneu­ monia is high and that the survival time of non-survivors is 1–2 weeks, the number of people infected in Italy will probably impose a major strain on critical care facilities in our hospitals, some of which do not have adequate resources or staff to deal with this emergency. In the Lombardy region, despite extraordinary efforts to restrict the movement of people at the expense of the Italian economy, we are dealing with an even greater fear—that the number of patients who present to the emergency room will become much greater than the system can cope with. The number of intensive care beds necessary to give the maximum number of patients the chance to be treated will reach several thousand, but the exact number is still a matter of discussion among experts. Health-care professionals have been working day and night since Feb 20, and in doing so around 20% (n=350) of them have become infected, and some have died. Lombardy is responding to the lack of beds for patients with COVID-19 by sending patients who need intensive care but are not infected with COVID-19 to hospitals outside of the region to contain the virus. Modelling predictions We present the following predictions to prepare our political leaders—those who bear the greatest respon­ sibility for national health systems and the government at the regional level, as well as local health authorities—for what is predicted to happen in the days and weeks to come. They can then implement measures regarding staff resources and hospital beds to meet the challenges of this difficult time. Official numbers of infected people during the COVID-19 virus outbreak in Italy are indicative of the spread of the infection, and of the challenges that will be posed to Italian hospitals and, in particular, intensive care facilities. The number of patients who are infected has been published daily since Feb 21, 2020. It is possible to fit the available data for the number of patients who are actively infected into an exponential model, as reported in figure 1A. The value of the exponent can be computed as r=0·225 (1 per day) and is consistent with the number of infected patients reported by the Italian Health Ministry. The consistency between the exponential prediction and the reported data is very close up until day 17. If the increase in the number of infected patients follows this trend for the next week, there will be more than 30 000 patients infected by March 15, as shown in figure 1B. On the basis of the exponential curve prediction, and the assumption that the duration of infection ranges from 15 to 20 days, it is possible to calculate that the basic reproduction number ranges from 2·76 to 3·25. This number is similar to that reported for the initial phase of the infection outbreak in the city of Wuhan, China3 and slightly higher than 2·2, as reported by Li and colleagues in a more recent report.4 The number of patients admitted to intensive care units increased similarly in Italy, with an exponential trend up until March 8. The best fit of the data reported by the Italian Ministry for Health can be obtained using the same exponent that best fits the number of patients Figure2:Measured and predicted number of patients in intensive care units in Italy using an exponential curve Panel A shows number of patients in intensive care units in previous days and B shows projections for the coming days.The dotted line represents the estimated capacity of intensive care beds in Italy. Feb 27 Feb 29 March 2 March 4 March 6 March 8 March 10 0 100 200 300 400 500 600 700 1000 800 900 Numberofpatientsinintensivecareunits A March 16Feb 27 Feb 29 March 2 March 4 March 6 March 8 March 10 March 12 March 14 0 500 1000 1500 2000 2500 3500 3000 Numberofpatientsinintensivecareunits Date (2020) B Measured Simulated For the Italian Health Ministry see http://www.salute.gov.it/ portale/home.html
  • 3. Health Policy www.thelancet.com Published online March 12, 2019 https://doi.org/10.1016/S0140-6736(20)30627-9 3 who are infected, as shown in figure 2A. The data available up until March 8 show that the trend in the number of patients who will need admission to intensive care units will increase substan­tially and relentlessly in the next few days. We can predict with quite a good degree of accuracy that this number will push the national health system to full capacity in a matter of days. Considering that the number of available beds in intensive care units in Italy is close to 5200, and assuming that half of these beds can be used for patients with COVID-19, the system will be at maximum capacity, according to this prediction, by March 14, 2020. This situation is difficult, given that the number of patients who will need to be admitted to the intensive care unit is predicted to further increase after that date, as shown in figure 2B. At this point, the most important question is whether the increase in the number of patients who are infected and those requiring intensive care admittance will continue to rise exponentially and for how long. If the change in the slope of the curve does not take place soon, the clinical and social problems will take on unmanage­ able dimensions, which are expected to have catastrophic results. The only way we can make such predictions is by comparing the trends in the data collected in the Hubei region in China for COVID-19 infection with that for the Italian population. From the official report of the WHO– China Joint Mission on Coronavirus Disease 2019,5 it is possible to derive the cumulative curve of the patients who are infected from the start of the data series. These data, as reported in figure 3, show that the initial phase of the infection outbreak followed the expected exponential trend, with the same exponent previously calculated for the number of Italian patients who were infected. Starting Jan 7, the cumulative number of patients who were infected started to diverge from the exponential trend 20 days later. If the Italian outbreak follows a similar trend to that in China, we can suggest that the number of newly infected patients might start to decrease within 3–4 days from March 11. Similarly, we can foresee that the cumulative curve of patients who are infected will peak 30 days later, with the maximum load for clinical facilities for the treatment of these patients foreseen for that period. Discussion The most difficult prediction is the maximum number of infected patients that will be reached in Italy and, most importantly, the maximum number of patients who will require intensive care unit admission. This prediction is of crucial importance to plan for new facilities in Italian hospitals and to calculate the time period in which they need to be available. On the basis that the region of Hubei in China has a slightly smaller population than Italy (approximately 50 million in Hubei and 60 million in Italy), we tentatively assumed that the trend for the maximum number of patients who are actively infected would be similar in the two territories. In doing so, we cannot overlook the fact that the effect of travel restric­tions on the spread of the COVID-19 outbreak and the extraordinary community measures taken within and outside of Wuhan are unlikely to be replicated elsewhere. Moreover, the current approach to these patients in Lombardy implies non-pharmacological and pharma­ cological interventions, including antiretroviral medi­ cation, which might be different from the Wuhan outbreak, and could distort the calculation. We also realise that there is heterogeneity in the transmission dynamics between the city of Wuhan and elsewhere in the province, where the number of people who are infected remains lower. Therefore, it might not be unrealistic to assume that what is going to happen in Italy soon might mirror what happened in Hubei. Of course, it would have been more appropriate to directly compare Greater Wuhan (19 million people) with the region of Lombardy (9 million people), the most seriously affected region in Italy at the moment, but such data are not available.6 We do not currently have additional evidence we can take into consideration to make more robust assumptions regarding the exact number of patients who will be infected in the future days or weeks. On the basis of the available data,5 the number of infected patients reached approximately 38 000 at the end of February, 2020, in the Hubei region, when the number of new cases decreased to almost zero. Given that so far the percentage of patients requiring ARDS treatment is close to 10% for patients who are actively infected, at least in Lombardy, we can assume that we will need approximately 4000 beds in intensive care units during the worst period of infection, which is expected to occur in about 4 weeks from March 11. This is challenging for Italy, as there are now just over 5200 intensive care beds in total. The aim now is to increase this number to safely meet urgent future Figure 3: Fitting of cumulative curve of measured infected patients in Hubei,China, with an exponential curve The dotted line represents the timepoint of the infection outbreak in Italy. It is expected that the number of cumulative patients who are infected will start to deviate from the exponential low in 3–4 days.The plateau of the cumulative curve will be reached just over 30 days from March 11, 2020. Jan 5 Jan 10 Jan 15 Jan 20 Jan 25 Jan 30 Feb 4 Feb 9 Feb 14 Feb 19 Feb 24 0 10000 20000 30000 40000 50000 60000 Numberofinfectedpatients Date (2020) Measured Simulated
  • 4. Health Policy 4 www.thelancet.com Published online March 12, 2019 https://doi.org/10.1016/S0140-6736(20)30627-9 needs. According to our prediction, we have only a few weeks to achieve this goal in terms of procuring personnel, technical equipment, and materials. These considerations might also apply to other European countries that could have similar numbers of patients infected and similar needs regarding intensive care admissions. Since 1978, Italy has had the privilege of having a national health system (Servizio Sanitario Nazionale), which was reshaped from 1992–93. Its principles and organisation derive from the British National Health Service model, and it is based on three fundamental principles. The first principle is universality—all citizens have an equal right to access services provided by the national health system. The second is solidarity—every citizen contributes to financing the national health service based on their means, through progressive taxation. The third is uniformity—the quality of the services provided by the national health service to all citizens in all regions must be uniform. All individuals are supposed to pay for it as taxpayers, each person giving a little to receive a lot in return, if they become unwell. Conclusion In theory, we are in a better position than many other countries to react to the current outbreak. However, an aggressive approach needs to be taken with patients who are critically ill with SARS-CoV-2, often including ventilatory support. The system’s capacity to respond to changing circumstances has been under enormous pressure, at least in the Lombardy region, where two clusters have already emerged since Feb 21. We predict that if the exponential trend continues for the next few days, more than 2500 hospital beds for patients in intensive care units will be needed in only 1 week to treat ARDS caused by SARS-CoV-2-pneumonia in Italy. In the meantime, the government is preparing to pass legislation that will enable the health service to hire 20 000 more doctors and nurses and to provide 5000 more ventilators to Italian hospitals. These measures are a step in the right direction, but our model tells us that they need to be implemented urgently, in a matter of days. Otherwise, a substantial number of unnecessary deaths will become inevitable. Intensive care specialists are already considering denying life-saving care to the sickest and giving priority to those patients most likely to survive when deciding who to provide ventilation to. This attitude has already been criticised by the current President of the Italian Comitato di Bioetica who, in a recent declaration to lay press stated that the Constitution recognises the right of every individual to receive all necessary health care. They might not recognise that the reality is that intensive care wards are overflowing with patients and that COVID-19 is not a benign disease. Our doctors and nurses are modern heroes in an unexpected war against a difficult enemy. In the near future, they will have no choice. They will have to follow the same rules that health-care workers are left with in conflict and disaster zones. We hope that the present analysis will help political leaders and health authorities to move as quickly as they can to ensure that there are enough resources, including personnel, hospital beds, and intensive care facilities, for what is going to happen in the next few days and weeks. Finally, our analysis tends to suggest that measures to reduce transmission should certainly be implemented, as our government did on March 9, by inhibiting people’s movement and social activities, unless strictly required. Rather than revising the Schengen visa-free zone, the most effective way to contain this viral outbreak in European countries is probably to avoid close contact at the individual level and social meetings in each country. Contributors AR was responsible for data analysis and statistics, and writing of the manuscript. GR was responsible for data analysis and writing of the manuscript. Declarations of interest We declare no competing interests. Acknowledgments We thank Kerstin Mierke for writing assistance. References 1 Callaway E. Time to use the p-word? Coronavirus enter dangerous new phase. Nature 2020; 579: 12. 2 The Economist. Tourism flows and death rates suggest covid-19 is being under-reported. 2020. https://www.economist.com/graphic- detail/2020/03/07/tourism-flows-and-death-rates-suggest-covid-19- is-being-under-reported (accessed March 11, 2020). 3 Leung G, Wuhttps J. Real-time nowcast and forecast on the extent of the Wuhan CoV outbreak, domestic and international spread. 2020. https://www.med.hku.hk/f/news/3549/7418/Wuhan- coronavirus-outbreak_AN-UPDATE_20200127.pdf (accessed March 11, 2020). 4 Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020; published online Jan 29. DOI:10.1056/NEJMoa2001316. 5 Joint Mission. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020. https://www.who.int/ docs/default-source/coronaviruse/who-china-joint-mission-on- covid-19-final-report.pdf (accessed March 11, 2020). 6 Johns Hopkins Center for Systems Science and Engineering. Coronavirus COVID-19 Global Cases. 2020. https://systems.jhu. edu/research/public-health/ncov/ (accessed March 11, 2020). © 2020 Elsevier Ltd. All rights reserved.